rheumatology
Osteoarthritis

Hyaluronate another case of practice not meeting guidelines

A summary of the current conflicting literature on the use of intraarticular hyaluronate in OA suggests at best a small treatment benefit which is quickly outweighed by the cost and adverse events, writes David Hunter in a case study education piece in the NEJM. Despite insufficient evidence of its efficacy it was a treatment that was still ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic